By Pat Sullivan, Contributing Editor
Today’s issue of WorkCompRecap features a guest post from Phil Walls R.Ph., Chief Clinical and Compliance Officer at myMatrixx, on the fairly new category of Specialty Drugs and how it is time to re-think the traditional savings reported by pharmacy benefit managers (PBMs) in order to recognize the true savings generated by some drugs. Phil notes the importance of moving away from “siloed” thinking when considering savings, as focusing too narrowly on savings in just the pharmacy silo may result in missing out on other major savings in the bigger picture.
Read Phil’s post on WorkCompWire by clicking here!
Want more Specialty Drug insights? Check out our Partner Post from Healthesystems!
myMatrixx and Healthesystems are WorkCompWire advertising partners.
This is not a paid placement.